InfuSystems Holdings Inc (INFU)
6.75
+0.19
(+2.90%)
USD |
NYAM |
Sep 27, 16:00
6.72
-0.03
(-0.44%)
After-Hours: 20:00
InfuSystems Holdings SG&A Expense (TTM): 59.37M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 59.37M |
March 31, 2024 | 59.14M |
December 31, 2023 | 56.88M |
September 30, 2023 | 56.21M |
June 30, 2023 | 56.40M |
March 31, 2023 | 56.09M |
December 31, 2022 | 56.41M |
September 30, 2022 | 54.77M |
June 30, 2022 | 54.59M |
March 31, 2022 | 53.86M |
December 31, 2021 | 51.45M |
September 30, 2021 | 53.14M |
June 30, 2021 | 49.45M |
March 31, 2021 | 46.32M |
December 31, 2020 | 44.86M |
September 30, 2020 | 42.70M |
June 30, 2020 | 41.26M |
March 31, 2020 | 40.45M |
December 31, 2019 | 38.92M |
September 30, 2019 | 36.36M |
June 30, 2019 | 35.64M |
March 31, 2019 | 35.01M |
December 31, 2018 | 33.74M |
September 30, 2018 | 33.72M |
June 30, 2018 | 32.93M |
Date | Value |
---|---|
March 31, 2018 | 32.93M |
December 31, 2017 | 33.82M |
September 30, 2017 | 34.22M |
June 30, 2017 | 34.16M |
March 31, 2017 | 34.15M |
December 31, 2016 | 34.29M |
September 30, 2016 | 34.43M |
June 30, 2016 | 35.01M |
March 31, 2016 | 34.97M |
December 31, 2015 | 34.20M |
September 30, 2015 | 32.98M |
June 30, 2015 | 32.04M |
March 31, 2015 | 30.88M |
December 31, 2014 | 29.73M |
September 30, 2014 | 29.21M |
June 30, 2014 | 28.79M |
March 31, 2014 | 28.76M |
December 31, 2013 | 28.63M |
September 30, 2013 | 29.51M |
June 30, 2013 | 30.16M |
March 31, 2013 | 31.35M |
December 31, 2012 | 32.93M |
September 30, 2012 | 32.36M |
June 30, 2012 | 31.52M |
March 31, 2012 | 29.42M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
36.36M
Minimum
Sep 2019
59.37M
Maximum
Jun 2024
50.43M
Average
53.50M
Median
SG&A Expense (TTM) Benchmarks
Plus Therapeutics Inc | 8.793M |
Perspective Therapeutics Inc | 18.64M |
Retractable Technologies Inc | 19.15M |
Xtant Medical Holdings Inc | 79.82M |
Catheter Precision Inc | 10.84M |